XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED SPONSORED INVESTMENT PRODUCTS - Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 637.3 $ 511.7
Net cash provided by (used in) investing activities (8.6) (57.5)
Net cash provided by (used in) financing activities (267.8) (144.2)
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products (0.8) 1.5
Net change in cash and cash equivalents during period 360.1 311.5
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 2,143.8 1,874.7
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products 2,503.9 2,186.2
Consolidated T. Rowe Price investment products    
Condensed Cash Flow Statements, Captions [Line Items]    
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 77.2 119.1
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products 87.4 92.1
Reportable entities | Consolidated T. Rowe Price investment products    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (95.7) (159.6)
Net cash provided by (used in) investing activities (0.1) (2.5)
Net cash provided by (used in) financing activities 106.8 133.6
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products (0.8) 1.5
Net change in cash and cash equivalents during period 10.2 (27.0)
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 77.2 119.1
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products 87.4 92.1
Reportable entities | Voting interest entities    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (61.8) (12.4)
Net cash provided by (used in) investing activities 0.0 0.0
Net cash provided by (used in) financing activities 72.7 4.4
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products 0.0 0.0
Net change in cash and cash equivalents during period 10.9 (8.0)
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 25.7 16.2
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products 36.6 8.2
Reportable entities | Variable interest entities    
Condensed Cash Flow Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (33.9) (147.2)
Net cash provided by (used in) investing activities (0.1) (2.5)
Net cash provided by (used in) financing activities 34.1 129.2
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products (0.8) 1.5
Net change in cash and cash equivalents during period (0.7) (19.0)
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 51.5 102.9
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products $ 50.8 $ 83.9